Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

被引：2
|
作者：
Levy, Benjamin Philip
Paz-Ares, Luis G.
Bennouna, Jaafar
Felip, Enriqueta
Abreu, Delvys Rodriguez
Isla, Dolores
Barlesi, Fabrice
Molinier, Olivier
Madelaine, Jeannick
Audigier-Valette, Clarisse
Kim, Sang-We
Ozguroglu, Mustafa
Erman, Mustafa
Badin, Firas Benyamine
Mekhail, Tarek
Scheff, Ronald J.
Riess, Jonathan W.
机构：
[1] Johns Hopkins Univ, Sch Med, Sibley Mem Hosp, Sidney Kimmel Comprehens Canc Ctr, Washington, DC USA
[2] Hosp Univ 12 Octubre, Madrid, Spain
[3] CNIO, Madrid, Spain
[4] Hop G & L Laennec, Nantes, France
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[7] Hosp Clin Lozano Blesa, Zaragoza, Spain
[8] Hosp Nord Serv Oncol, Marseille, France
[9] Ctr Hosp Le Mans, Le Mans, France
[10] Hopital Cote Nacre, Caen, France
[11] Hop St Musse, Toulon, France
[12] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[13] Istanbul Univ, Istanbul, Turkey
[14] Hacettepe Univ, Inst Canc, Ankara, Turkey
[15] Baptist Hlth Lexington Canc Ctr, Lexington, KY USA
[16] Florida Hosp Canc Inst, Orlando, FL USA
[17] Weill Cornell Med Coll, New York, NY USA
[18] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS9117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9117
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
    Besse, B.
    Garrido Lopez, P.
    Puente, J.
    Cortot, A.
    Olmedo Garcia, M. E.
    Perol, M.
    Gil, M.
    Chao, G.
    Shahidi, J.
    Bennouna, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer
    Elmushraf, R.
    Clinch, H.
    Salawu, A.
    Fisher, P.
    Young, R.
    Lee, C.
    Danson, S.
    Bates, E.
    Hatton, M.
    Low, L.
    Das, T.
    Taylor, F.
    LUNG CANCER, 2019, 127 : S43 - S43
  • [23] Pembrolizumab resolves adult ashy dermatosis developing in patients with squamous cell carcinoma of the lung
    Takeda, Kana
    Fujimura, Taku
    Tsuchiyama, Kenichiro
    Lyu, Chunbing
    Aiba, Setsuya
    JOURNAL OF DERMATOLOGY, 2019, 46 (03): : 271 - 273
  • [24] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [25] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Ukena, D
    Berg, M
    Leutz, M
    Zell, L
    Schlimmer, P
    Sybrecht, GW
    LUNG CANCER, 1998, 19 (01) : 31 - 36
  • [26] Efficacy of pembrolizumab in patients with cutaneous squamous cell carcinoma
    Ferrarotto, R.
    Glisson, B.
    Blumenschein, G.
    Hong, D.
    Piha-Paul, S.
    Ahnert, J. Rodon
    Pant, S.
    Tsimberidou, A.
    Janku, F.
    Alshawa, A.
    Jain, D.
    Rejon, M.
    Hess, K.
    Colen, R.
    Lu, C.
    Stephen, B.
    Tapia, C.
    Mendoza, T.
    Meric-Bernstam, F.
    Naing, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E75 - E75
  • [27] Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients
    Hsu, En-Chi
    Wu, Kuan-Li
    Tsai, Ying-Ming
    Lee, Mei-Hsuan
    Tsai, Ming-Ju
    Kuo, Chia-Yu
    Liu, Yu-Chuan
    Liang, Fu-Wen
    Yang, Chih-Jen
    Hung, Jen-Yu
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (10): : 1001 - 1011
  • [28] A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
    Reck, M.
    Mileham, K. F.
    Clump, D. A.
    Decoster, L.
    Estival, A.
    Felip, E.
    Fried, P.
    Paz-Ares, L.
    Sebastian, M.
    Vinolas Segarra, N.
    Surmont, V.
    Wagner, A.
    Galdy, S. M.
    Smit, E. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S897 - S898
  • [29] PHASE II TRIAL OF AFATINIB AS A THIRD-LINE TREATMENT FOR KOREAN PATIENTS (PTS) WITH WILD-TYPE EPIDERMAL GROWTH FACTOR RECEPTOR (WTEGFR) STAGE IIIB/IV LUNG ADENOCARCINOMA
    Ahn, M. A.
    Kim, S.
    Cho, B.
    Ahn, J. S.
    Lee, D. H.
    Sun, J.
    Massey, D.
    Kim, M.
    Shi, Y.
    Park, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 424 - 424
  • [30] Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of Afatinib
    Santos, Edgardo S.
    Hart, Lowell
    ONCOTARGETS AND THERAPY, 2020, 13 : 9305 - 9321
12345